132 related articles for article (PubMed ID: 3383353)
1. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
Bitterman H; Smith BA; Lefer AM
Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
[TBL] [Abstract][Full Text] [Related]
2. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
Bitterman H; Lefer DJ; Lefer AM
Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):341-7. PubMed ID: 3116357
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
Hock CE; Lefer AM
Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503
[TBL] [Abstract][Full Text] [Related]
4. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
Stahl GL; Bitterman H; Terashita Z; Lefer AM
Eur J Pharmacol; 1988 May; 149(3):233-40. PubMed ID: 3409951
[TBL] [Abstract][Full Text] [Related]
5. Oxygen therapy in hemorrhagic shock.
Bitterman H; Reissman P; Bitterman N; Melamed Y; Cohen L
Circ Shock; 1991 Mar; 33(3):183-91. PubMed ID: 2044210
[TBL] [Abstract][Full Text] [Related]
6. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
Bitterman H; Yanagisawa A; Lefer AM
Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
[TBL] [Abstract][Full Text] [Related]
7. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
Karasawa A; Rochester JA; Lefer AM
Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
[TBL] [Abstract][Full Text] [Related]
8. Use of hypertonic saline in the treatment of hemorrhagic shock.
Bitterman H; Triolo J; Lefer AM
Circ Shock; 1987; 21(4):271-83. PubMed ID: 3581442
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of two leukotriene antagonists in rat traumatic shock.
Levitt MA; Lefer AM
Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754
[TBL] [Abstract][Full Text] [Related]
10. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
Bitterman H; Smith BA; Lefer AM
Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of action of PGE1 in hemorrhagic shock in rats.
Bitterman H; Stahl GL; Terashita Z; Lefer AM
Ann Emerg Med; 1988 May; 17(5):457-62. PubMed ID: 3364825
[TBL] [Abstract][Full Text] [Related]
12. Protective actions of S-nitroso-N-acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock.
Symington PA; Ma XL; Lefer AM
Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):789-97. PubMed ID: 1338473
[TBL] [Abstract][Full Text] [Related]
13. Effects of prostacyclin and taprostene in splanchnic artery occlusion shock.
VanAntwerp DR; Hedley LR; Spires DA; Strosberg AM; Johnson G; Lefer AM
Eicosanoids; 1991; 4(1):15-20. PubMed ID: 2059456
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
Hock CE; Lefer AM
Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462
[TBL] [Abstract][Full Text] [Related]
15. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
Karasawa A; Rochester JA; Lefer AM
Circ Shock; 1992 Feb; 36(2):154-61. PubMed ID: 1582007
[TBL] [Abstract][Full Text] [Related]
16. Salutary effects of CG-4203, a novel, stable prostacyclin analog, in hemorrhagic shock.
Bitterman H; Smith BA; Lefer DJ; Lefer AM
J Cardiovasc Pharmacol; 1988 Sep; 12(3):293-9. PubMed ID: 2464101
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
Bitterman H; Phillips GR; Dragon G; Lefer AM
J Pharmacol Exp Ther; 1987 Jul; 242(1):8-14. PubMed ID: 3039116
[TBL] [Abstract][Full Text] [Related]
18. Salutary effects of anisodamine in murine traumatic shock.
Hock CE; Su JY; Lefer AM
Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
[TBL] [Abstract][Full Text] [Related]
19. Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats.
Freeman JG; Hock CE; Edmonds JS; Lefer AM
J Pharmacol Exp Ther; 1984 Dec; 231(3):610-5. PubMed ID: 6094795
[TBL] [Abstract][Full Text] [Related]
20. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642.
Hock CE; Lefer DJ; Lefer AM
Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
